Abstract
Approximately 25% of patients with end-stage renal disease (ESRD) have concomitant peripheral artery disease (PAD). Although kidney transplantation increases overall survival and quality of life in patients with ESRD, these patients remain at high risk for post-transplant sequelae related to PAD, including lower extremity revascularization procedures and amputations. The objective of this study was to determine the incidence of, and risk factors for, lower extremity vascular intervention (LEVI) following kidney transplantation using the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) dataset.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
